Koyfin Home > Directory > Health Care > Aclaris Therapts > EBITDA Margin

Aclaris Therapts EBITDA Margin Chart (ACRS)

Aclaris Therapts annual/quarterly EBITDA Margin from 2017 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Aclaris Therapts EBITDA Margin for the quarter ending June 06, 2020 was $-539m a -308.89% increase of 1,665m year over year
  • Aclaris Therapts EBITDA Margin for the last 12 months ending June 06, 2020 was $-1,203m a -61.98% increase of 746m year over year
  • Aclaris Therapts Annual EBITDA Margin for 2019 was $-2,113m a 36.78% decrease of -777m from 2018
  • Aclaris Therapts Annual EBITDA Margin for 2018 was $-1,336m a -137.72% increase of 1,840m from 2017
  • Aclaris Therapts Annual EBITDA Margin for 2017 was $-3,176m
Other Margins & Efficiency Metrics:
  • Aclaris Therapts Return on Capital % for the quarter ending September 09, 2018 was -52.09 a 49.02% decrease of -25.54 year over year
  • Aclaris Therapts Return on Equity % for the quarter ending September 09, 2018 was -81.71 a 52.18% decrease of -42.64 year over year
View Chart On Koyfin

Quarterly ACRS EBITDA Margin Data

06/2020$-539m
03/2020$-948m
12/2019$-1,548m
09/2019$-2,204m
06/2019$-2,514m
03/2019$-1,977m
12/2018$-1,302m
09/2018$-1,889m
03/2018$-2,671m
12/2017$-2,478m

Annual ACRS EBITDA Margin Data

2019$-2,113m
2018$-1,336m
2017$-3,176m